<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34077532</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2083</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>19</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>15</Day></PubDate></JournalIssue><Title>Human molecular genetics</Title><ISOAbbreviation>Hum Mol Genet</ISOAbbreviation></Journal><ArticleTitle>Toxicity of pathogenic ataxin-2 in Drosophila shows dependence on a pure CAG repeat sequence.</ArticleTitle><Pagination><StartPage>1797</StartPage><EndPage>1810</EndPage><MedlinePgn>1797-1810</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/hmg/ddab148</ELocationID><Abstract><AbstractText>Spinocerebellar ataxia type 2 is a polyglutamine (polyQ) disease associated with an expanded polyQ domain within the protein product of the ATXN2 gene. Interestingly, polyQ repeat expansions in ATXN2 are also associated with amyotrophic lateral sclerosis (ALS) and parkinsonism depending upon the length of the polyQ repeat expansion. The sequence encoding the polyQ repeat also varies with disease presentation: a pure CAG repeat is associated with SCA2, whereas the CAG repeat in ALS and parkinsonism is typically interrupted with the glutamine encoding CAA codon. Here, we asked if the purity of the CAG sequence encoding the polyQ repeat in ATXN2 could impact the toxicity of the ataxin-2 protein in vivo in Drosophila. We found that ataxin-2 encoded by a pure CAG repeat conferred toxicity in the retina and nervous system, whereas ataxin-2 encoded by a CAA-interrupted repeat or CAA-only repeat failed to confer toxicity, despite expression of the protein at similar levels. Furthermore, the CAG-encoded ataxin-2 protein aggregated in the fly eye, while ataxin-2 encoded by either a CAA/G or CAA repeat remained diffuse. The toxicity of the CAG-encoded ataxin-2 protein was also sensitive to the translation factor eIF4H, a known modifier of the toxic GGGGCC repeat in flies. These data indicate that ataxin-2 encoded by a pure CAG versus interrupted CAA/G polyQ repeat domain is associated with differential toxicity, indicating that mechanisms associated with the purity of the sequence of the polyQ domain contribute to disease.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2021. Published by Oxford University Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McGurk</LastName><ForeName>Leeanne</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Cell &amp; Developmental Biology, School of Life Sciences, University of Dundee, Dundee, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biology, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rifai</LastName><ForeName>Olivia M</ForeName><Initials>OM</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shcherbakova</LastName><ForeName>Oksana</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perlegos</LastName><ForeName>Alexandra E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Neurosciences Graduate Group, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Byrns</LastName><ForeName>China N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Neurosciences Graduate Group, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Sciences Training Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carranza</LastName><ForeName>Faith R</ForeName><Initials>FR</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Henry W</ForeName><Initials>HW</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hyung-Jun</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Yongqing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonini</LastName><ForeName>Nancy M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurosciences Graduate Group, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R35 NS097275</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM007229</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P40 OD018537</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F31 AG063470</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AG000255</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F31 NS111868</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hum Mol Genet</MedlineTA><NlmUniqueID>9208958</NlmUniqueID><ISSNLinking>0964-6906</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067698">Ataxin-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067528">Ataxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI="D000067699">Ataxin-3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067698" MajorTopicYN="N">Ataxin-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067699" MajorTopicYN="N">Ataxin-3</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067528" MajorTopicYN="N">Ataxins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004330" MajorTopicYN="N">Drosophila</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020754" MajorTopicYN="Y">Spinocerebellar Ataxias</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019680" MajorTopicYN="N">Trinucleotide Repeat Expansion</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>2</Day><Hour>17</Hour><Minute>26</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34077532</ArticleId><ArticleId IdType="pmc">PMC8444453</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddab148</ArticleId><ArticleId IdType="pii">6291182</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adegbuyiro, A., Sedighi, F., Pilkington, A.W., Groover, S. and Legleiter, J. (2017) Proteins containing expanded polyglutamine tracts and neurodegenerative disease. Biochemistry, 56, 1199&#x2013;1217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5727916</ArticleId><ArticleId IdType="pubmed">28170216</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoyas, C.A. and La Spada, A.R. (2018) The CAG-polyglutamine repeat diseases: a clinical, molecular, genetic, and pathophysiologic nosology. Handb. Clin. Neurol., 147, 143&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">29325609</ArticleId></ArticleIdList></Reference><Reference><Citation>Galka-Marciniak, P., Urbanek, M.O. and Krzyzosiak, W.J. (2012) Triplet repeats in transcripts: structural insights into RNA toxicity. Biol. Chem., 393, 1299&#x2013;1315.</Citation><ArticleIdList><ArticleId IdType="pubmed">23052488</ArticleId></ArticleIdList></Reference><Reference><Citation>Klockgether, T., Mariotti, C. and Paulson, H.L. (2019) Spinocerebellar ataxia. Nat. Rev. Dis. Primers., 5, 24.</Citation><ArticleIdList><ArticleId IdType="pubmed">30975995</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalavade, R., Griesche, N., Ryan, D.P., Hildebrand, S. and Krauss, S. (2013) Mechanisms of RNA-induced toxicity in CAG repeat disorders. Cell Death Dis., 4, e752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3763438</ArticleId><ArticleId IdType="pubmed">23907466</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller, J.W., Urbinati, C.R., Teng-Umnuay, P., Stenberg, M.G., Byrne, B.J., Thornton, C.A. and Swanson, M.S. (2000) Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J., 19, 4439&#x2013;4448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC302046</ArticleId><ArticleId IdType="pubmed">10970838</ArticleId></ArticleIdList></Reference><Reference><Citation>Mankodi, A., Urbinati, C.R., Yuan, Q.P., Moxley, R.T., Sansone, V., Krym, M., Henderson, D., Schalling, M., Swanson, M.S. and Thornton, C.A. (2001) Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum. Mol. Genet., 10, 2165&#x2013;2170.</Citation><ArticleIdList><ArticleId IdType="pubmed">11590133</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang, H., Mankodi, A., Swanson, M.S., Moxley, R.T. and Thornton, C.A. (2004) Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum. Mol. Genet., 13, 3079&#x2013;3088.</Citation><ArticleIdList><ArticleId IdType="pubmed">15496431</ArticleId></ArticleIdList></Reference><Reference><Citation>Moseley, M.L., Zu, T., Ikeda, Y., Gao, W., Mosemiller, A.K., Daughters, R.S., Chen, G., Weatherspoon, M.R., Clark, H.B., Ebner, T.J., et al. (2006) Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nat. Genet., 38, 758&#x2013;769.</Citation><ArticleIdList><ArticleId IdType="pubmed">16804541</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash, P.E.A., Bieniek, K.F., Gendron, T.F., Caulfield, T., Lin, W.-L., Dejesus-Hernandez, M., van &#xa0;Blitterswijk, M.M., Jansen-West, K., Paul, J.W., Rademakers, R., et al. (2013) Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron, 77, 639&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori, K., Weng, S.-M., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H.A., Cruts, M., Van Broeckhoven, C., et al. (2013) The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science, 339, 1335&#x2013;1338.</Citation><ArticleIdList><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu, T., Gibbens, B., Doty, N.S., Gomes-Pereira, M., Huguet, A., Stone, M.D., Margolis, J., Peterson, M., Markowski, T.W., Ingram, M.A.C., et al. (2011) Non-ATG-initiated translation directed by microsatellite expansions. Proc. Natl. Acad. Sci. U. S. A., 108, 260&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3017129</ArticleId><ArticleId IdType="pubmed">21173221</ArticleId></ArticleIdList></Reference><Reference><Citation>Ba&#xf1;ez-Coronel, M., Ayhan, F., Tarabochia, A.D., Zu, T., Perez, B.A., Tusi, S.K., Pletnikova, O., Borchelt, D.R., Ross, C.A., Margolis, R.L., et al. (2015) RAN translation in Huntington disease. Neuron, 88, 667&#x2013;677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4684947</ArticleId><ArticleId IdType="pubmed">26590344</ArticleId></ArticleIdList></Reference><Reference><Citation>Green, K.M., Glineburg, M.R., Kearse, M.G., Flores, B.N., Linsalata, A.E., Fedak, S.J., Goldstrohm, A.C., Barmada, S.J. and Todd, P.K. (2017) RAN translation at C9orf72-associated repeat expansions is selectively enhanced by the integrated stress response. Nat. Commun., 8, 2005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5722904</ArticleId><ArticleId IdType="pubmed">29222490</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng, W., Wang, S., Zhang, Z., Morgens, D.W., Hayes, L.R., Lee, S., Portz, B., Xie, Y., Nguyen, B.V., Haney, M.S., et al. (2019) CRISPR-Cas9 screens identify the RNA helicase DDX3X as a repressor of C9ORF72 (GGGGCC)n repeat-associated non-AUG translation. Neuron, 104, 885&#x2013;898.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6895427</ArticleId><ArticleId IdType="pubmed">31587919</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, L.-B., Yu, Z., Teng, X. and Bonini, N.M. (2008) RNA toxicity is a component of ataxin-3 degeneration in Drosophila. Nature, 453, 1107&#x2013;1111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2574630</ArticleId><ArticleId IdType="pubmed">18449188</ArticleId></ArticleIdList></Reference><Reference><Citation>Scoles, D.R., Ho, M.H.T., Dansithong, W., Pflieger, L.T., Petersen, L.W., Thai, K.K. and Pulst, S.M. (2015) Repeat associated non-AUG translation (RAN translation) dependent on sequence downstream of the ATXN2 CAG repeat. PLoS One, 10, e0128769.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4472729</ArticleId><ArticleId IdType="pubmed">26086378</ArticleId></ArticleIdList></Reference><Reference><Citation>Imbert, G., Saudou, F., Yvert, G., Devys, D., Trottier, Y., Garnier, J.M., Weber, C., Mandel, J.L., Cancel, G., Abbas, N., et al. (1996) Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat. Genet., 14, 285&#x2013;291.</Citation><ArticleIdList><ArticleId IdType="pubmed">8896557</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulst, S.M., Nechiporuk, A., Nechiporuk, T., Gispert, S., Chen, X.N., Lopes-Cendes, I., Pearlman, S., Starkman, S., Orozco-Diaz, G., Lunkes, A., et al. (1996) Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat. Genet., 14, 269&#x2013;276.</Citation><ArticleIdList><ArticleId IdType="pubmed">8896555</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanpei, K., Takano, H., Igarashi, S., Sato, T., Oyake, M., Sasaki, H., Wakisaka, A., Tashiro, K., Ishida, Y., Ikeuchi, T., et al. (1996) Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat. Genet., 14, 277&#x2013;284.</Citation><ArticleIdList><ArticleId IdType="pubmed">8896556</ArticleId></ArticleIdList></Reference><Reference><Citation>Paulson, H.L., Shakkottai, V.G., Clark, H.B. and Orr, H.T. (2017) Polyglutamine spinocerebellar ataxias - from genes to potential treatments. Nat. Rev. Neurosci., 18, 613&#x2013;626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6420820</ArticleId><ArticleId IdType="pubmed">28855740</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh, D.P., Del Bigio, M.R., Ho, D.H. and Pulst, S.M. (1999) Expression of ataxin-2 in brains from normal individuals and patients with Alzheimer&#x2019;s disease and spinocerebellar ataxia 2. Ann. Neurol., 45, 232&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pubmed">9989626</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh, D.P., Figueroa, K., Hoang, N. and Pulst, S.M. (2000) Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human. Nat. Genet., 26, 44&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">10973246</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrowski, L.A., Hall, A.C. and Mekhail, K. (2017) Ataxin-2: from RNA control to human health and disease. G. E. N., 8, 157. doi: 10.3390/genes8060157.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes8060157</ArticleId><ArticleId IdType="pmc">PMC5485521</ArticleId><ArticleId IdType="pubmed">28587229</ArticleId></ArticleIdList></Reference><Reference><Citation>Scoles, D.R. and Pulst, S.M. (2018) Spinocerebellar ataxia type 2. Adv. Exp. Med. Biol., 1049, 175&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pubmed">29427103</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden, A.C., Kim, H.-J., Hart, M.P., Chen-Plotkin, A.S., Johnson, B.S., Fang, X., Armakola, M., Geser, F., Greene, R., Lu, M.M., et al. (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature, 466, 1069&#x2013;1075.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann, M., Sampathu, D.M., Kwong, L.K., Truax, A.C., Micsenyi, M.C., Chou, T.T., Bruce, J., Schuck, T., Grossman, M., Clark, C.M., et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314, 130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, H.-J., Raphael, A.R., LaDow, E.S., McGurk, L., Weber, R.A., Trojanowski, J.Q., Lee, V.M.-Y., Finkbeiner, S., Gitler, A.D. and Bonini, N.M. (2014) Therapeutic modulation of eIF2&#x3b1; phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat. Genet., 46, 152&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3934366</ArticleId><ArticleId IdType="pubmed">24336168</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker, L.A., Huang, B., Bieri, G., Ma, R., Knowles, D.A., Jafar-Nejad, P., Messing, J., Kim, H.J., Soriano, A., Auburger, G., et al. (2017) Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature, 544, 367&#x2013;371.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5642042</ArticleId><ArticleId IdType="pubmed">28405022</ArticleId></ArticleIdList></Reference><Reference><Citation>Furtado, S., Farrer, M., Tsuboi, Y., Klimek, M.L., de la &#xa0;Fuente-Fern&#xe1;ndez, R., Hussey, J., Lockhart, P., Calne, D.B., Suchowersky, O., Stoessl, A.J., et al. (2002) SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findings. Neurology, 59, 1625&#x2013;1627.</Citation><ArticleIdList><ArticleId IdType="pubmed">12451209</ArticleId></ArticleIdList></Reference><Reference><Citation>Payami, H., Nutt, J., Gancher, S., Bird, T., McNeal, M.G., Seltzer, W.K., Hussey, J., Lockhart, P., Gwinn-Hardy, K., Singleton, A.A., et al. (2003) SCA2 may present as levodopa-responsive parkinsonism. Mov. Disord. Off. J. Mov. Disord. Soc., 18, 425&#x2013;429.</Citation><ArticleIdList><ArticleId IdType="pubmed">12671950</ArticleId></ArticleIdList></Reference><Reference><Citation>Infante, J., Berciano, J., Volpini, V., Corral, J., Polo, J.M., Pascual, J. and Combarros, O. (2004) Spinocerebellar ataxia type 2 with levodopa-responsive parkinsonism culminating in motor neuron disease. Mov. Disord. Off. J. Mov. Disord. Soc., 19, 848&#x2013;852.</Citation><ArticleIdList><ArticleId IdType="pubmed">15254952</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu, C.-S., Wu Chou, Y.-H., Kuo, P.-C., Chang, H.-C. and Weng, Y.-H. (2004) The parkinsonian phenotype of spinocerebellar ataxia type 2. Arch. Neurol., 61, 35&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">14732617</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe4;umer, D., East, S.Z., Tseu, B., Zeman, A., Hilton, D., Talbot, K. and Ansorge, O. (2014) FTLD-ALS of TDP-43 type and SCA2 in a family with a full ataxin-2 polyglutamine expansion. Acta Neuropathol. (Berl.), 128, 597&#x2013;604.</Citation><ArticleIdList><ArticleId IdType="pubmed">24718895</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosas, I., Mart&#xed;nez, C., Clarim&#xf3;n, J., Lle&#xf3;, A., Ill&#xe1;n-Gala, I., Dols-Icardo, O., Borroni, B., Almeida, M.R., van der &#xa0;Zee, J., Van Broeckhoven, C., et al. (2020) Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer&#x2019;s disease. Neurobiol. Aging, 87, 139.e1&#x2013;139.e7.</Citation><ArticleIdList><ArticleId IdType="pubmed">31810584</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, J.-M., Hong, S., Kim, G.P., Choi, Y.J., Kim, Y.K., Park, S.S., Kim, S.E. and Jeon, B.S. (2007) Importance of low-range CAG expansion and CAA interruption in SCA2 parkinsonism. Arch. Neurol., 64, 1510&#x2013;1518.</Citation><ArticleIdList><ArticleId IdType="pubmed">17923635</ArticleId></ArticleIdList></Reference><Reference><Citation>Fournier, C., Anquetil, V., Camuzat, A., Stirati-Buron, S., Sazdovitch, V., Molina-Porcel, L., Turbant, S., Rinaldi, D., S&#xe1;nchez-Valle, R., Barbier, M., et al. (2018) Interrupted CAG expansions in ATXN2 gene expand the genetic spectrum of frontotemporal dementias. Acta Neuropathol. Commun., 6, 41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5977499</ArticleId><ArticleId IdType="pubmed">29848387</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuenschwander, A.G., Thai, K.K., Figueroa, K.P. and Pulst, S.M. (2014) Amyotrophic lateral sclerosis risk for spinocerebellar ataxia type 2 ATXN2 CAG repeat alleles: a meta-analysis. JAMA Neurol., 71, 1529&#x2013;1534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4939089</ArticleId><ArticleId IdType="pubmed">25285812</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrado, L., Mazzini, L., Oggioni, G.D., Luciano, B., Godi, M., Brusco, A. and D&#x2019;Alfonso, S. (2011) ATXN-2 CAG repeat expansions are interrupted in ALS patients. Hum. Genet., 130, 575&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pubmed">21537950</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, Z., Zhu, Y., Chen-Plotkin, A.S., Clay-Falcone, D., McCluskey, L., Elman, L., Kalb, R.G., Trojanowski, J.Q., Lee, V.M.-Y., Van Deerlin, V.M., et al. (2011) PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats. PLoS One, 6, e17951.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3066214</ArticleId><ArticleId IdType="pubmed">21479228</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa, K.P., Coon, H., Santos, N., Velazquez, L., Mederos, L.A. and Pulst, S.-M. (2017) Genetic analysis of age at onset variation in spinocerebellar ataxia type 2. Neurol. Genet., 3, e155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5432368</ArticleId><ArticleId IdType="pubmed">28534046</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobczak, K. and Krzyzosiak, W.J. (2005) CAG repeats containing CAA interruptions form branched hairpin structures in spinocerebellar ataxia type 2 transcripts. J. Biol. Chem., 280, 3898&#x2013;3910.</Citation><ArticleIdList><ArticleId IdType="pubmed">15533937</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruber, A.R., Lorenz, R., Bernhart, S.H., Neub&#xf6;ck, R. and Hofacker, I.L. (2008) The Vienna RNA websuite. Nucleic Acids Res., 36, W70&#x2013;W74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2447809</ArticleId><ArticleId IdType="pubmed">18424795</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart, M.P., Brettschneider, J., Lee, V.M.Y., Trojanowski, J.Q. and Gitler, A.D. (2012) Distinct TDP-43 pathology in ALS patients with ataxin 2 intermediate-length polyQ expansions. Acta Neuropathol. (Berl.), 124, 221&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3543833</ArticleId><ArticleId IdType="pubmed">22526021</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, C.-R., Chang, C.-R., Chern, Y., Wang, T.-H., Hsieh, W.-C., Shen, W.-C., Chang, C.-Y., Chu, I.-C., Deng, N., Cohen, S.N., et al. (2012) Spt4 is selectively required for transcription of extended trinucleotide repeats. Cell, 148, 690&#x2013;701.</Citation><ArticleIdList><ArticleId IdType="pubmed">22341442</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer, N.J., Carlomagno, Y., Zhang, Y.-J., Almeida, S., Cook, C.N., Gendron, T.F., Prudencio, M., Van Blitterswijk, M., Belzil, V., Couthouis, J., et al. (2016) Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts. Science, 353, 708&#x2013;712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5823025</ArticleId><ArticleId IdType="pubmed">27516603</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman, L.D., Prudencio, M., Kramer, N.J., Martinez-Ramirez, L.F., Srinivasan, A.R., Lan, M., Parisi, M.J., Zhu, Y., Chew, J., Cook, C.N., et al. (2019) Toxic expanded GGGGCC repeat transcription is mediated by the PAF1 complex in C9orf72-associated FTD. Nat. Neurosci., 22, 863&#x2013;874.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6535128</ArticleId><ArticleId IdType="pubmed">31110321</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman, L.D. and Bonini, N.M. (2019) Repeat-associated non-AUG (RAN) translation mechanisms are running into focus for GGGGCC-repeat associated ALS/FTD. Prog. Neurobiol., 183, 101697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6941355</ArticleId><ArticleId IdType="pubmed">31550516</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman, L.D., Prudencio, M., Srinivasan, A.R., Rifai, O.M., Lee, V.M.-Y., Petrucelli, L. and Bonini, N.M. (2019) eIF4B and eIF4H mediate GR production from expanded G4C2 in a drosophila model for C9orf72-associated ALS. Acta Neuropathol. Commun., 7, 62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6485101</ArticleId><ArticleId IdType="pubmed">31023341</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng, H.-M., Chern, Y., Chen, I.-H., Liu, C.-R., Li, S.-H., Chun, S.J., Rigo, F., Bennett, C.F., Deng, N., Feng, Y., et al. (2015) Effects on murine behavior and lifespan of selectively decreasing expression of mutant huntingtin allele by supt4h knockdown. PLoS Genet., 11, e1005043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4356588</ArticleId><ArticleId IdType="pubmed">25760041</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuyumcu-Martinez, N.M., Wang, G.-S. and Cooper, T.A. (2007) Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol. Cell, 28, 68&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2083558</ArticleId><ArticleId IdType="pubmed">17936705</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawlor, K.T., O&#x2019;Keefe, L.V., Samaraweera, S.E., van &#xa0;Eyk, C.L., McLeod, C.J., Maloney, C.A., Dang, T.H.Y., Suter, C.M. and Richards, R.I. (2011) Double-stranded RNA is pathogenic in drosophila models of expanded repeat neurodegenerative diseases. Hum. Mol. Genet., 20, 3757&#x2013;3768.</Citation><ArticleIdList><ArticleId IdType="pubmed">21724553</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, Z., Teng, X. and Bonini, N.M. (2011) Triplet repeat-derived siRNAs enhance RNA-mediated toxicity in a drosophila model for myotonic dystrophy. PLoS Genet., 7, e1001340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3060073</ArticleId><ArticleId IdType="pubmed">21437269</ArticleId></ArticleIdList></Reference><Reference><Citation>Maga&#xf1;a, J.J., Vel&#xe1;zquez-P&#xe9;rez, L. and Cisneros, B. (2013) Spinocerebellar ataxia type 2: clinical presentation, molecular mechanisms, and therapeutic perspectives. Mol. Neurobiol., 47, 90&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">22996397</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xfc;b, U., Sch&#xf6;ls, L., Paulson, H., Auburger, G., Kermer, P., Jen, J.C., Seidel, K., Korf, H.-W. and Deller, T. (2013) Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7. Prog. Neurobiol., 104, 38&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">23438480</ArticleId></ArticleIdList></Reference><Reference><Citation>Charles, P., Camuzat, A., Benammar, N., Sellal, F., Dest&#xe9;e, A., Bonnet, A.-M., Lesage, S., Le Ber, I., Stevanin, G., D&#xfc;rr, A., et al. (2007) Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism? &#xa0;Neurology, 69, 1970&#x2013;1975.</Citation><ArticleIdList><ArticleId IdType="pubmed">17568014</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer, R.R., Pluciennik, A., Napierala, M. and Wells, R.D. (2015) DNA triplet repeat expansion and mismatch repair. Annu. Rev. Biochem., 84, 199&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4845744</ArticleId><ArticleId IdType="pubmed">25580529</ArticleId></ArticleIdList></Reference><Reference><Citation>Khristich, A.N. and Mirkin, S.M. (2020) On the wrong DNA track: molecular mechanisms of repeat-mediated genome instability. J. Biol. Chem., 295, 4134&#x2013;4170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7105313</ArticleId><ArticleId IdType="pubmed">32060097</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt, M.H.M. and Pearson, C.E. (2016) Disease-associated repeat instability and mismatch repair. DNA Repair, 38, 117&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">26774442</ArticleId></ArticleIdList></Reference><Reference><Citation>Swami, M., Hendricks, A.E., Gillis, T., Massood, T., Mysore, J., Myers, R.H. and Wheeler, V.C. (2009) Somatic expansion of the Huntington&#x2019;s disease CAG repeat in the brain is associated with an earlier age of disease onset. Hum. Mol. Genet., 18, 3039&#x2013;3047.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2714728</ArticleId><ArticleId IdType="pubmed">19465745</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung, J. and Bonini, N. (2007) CREB-binding protein modulates repeat instability in a drosophila model for polyQ disease. Science, 315, 1857&#x2013;1859.</Citation><ArticleIdList><ArticleId IdType="pubmed">17332375</ArticleId></ArticleIdList></Reference><Reference><Citation>Krzyzosiak, W.J., Sobczak, K., Wojciechowska, M., Fiszer, A., Mykowska, A. and Kozlowski, P. (2012) Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target. Nucleic Acids Res., 40, 11&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3245940</ArticleId><ArticleId IdType="pubmed">21908410</ArticleId></ArticleIdList></Reference><Reference><Citation>Schilling, J., Broemer, M., Atanassov, I., Duernberger, Y., Vorberg, I., Dieterich, C., Dagane, A., Dittmar, G., Wanker, E., van &#xa0;Roon-Mom, W., et al. (2019) Deregulated splicing is a major mechanism of RNA-induced toxicity in Huntington&#x2019;s disease. J. Mol. Biol., 431, 1869&#x2013;1877.</Citation><ArticleIdList><ArticleId IdType="pubmed">30711541</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian, B., White, R.J., Xia, T., Welle, S., Turner, D.H., Mathews, M.B. and Thornton, C.A. (2000) Expanded CUG repeat RNAs form hairpins that activate the double-stranded RNA-dependent protein kinase PKR. RNA N. Y. N, 6, 79&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1369895</ArticleId><ArticleId IdType="pubmed">10668800</ArticleId></ArticleIdList></Reference><Reference><Citation>Stochmanski, S.J., Therrien, M., Lagani&#xe8;re, J., Rochefort, D., Laurent, S., Karemera, L., Gaudet, R., Vyboh, K., Van Meyel, D.J., Di Cristo, G., et al. (2012) Expanded ATXN3 frameshifting events are toxic in drosophila and mammalian neuron models. Hum. Mol. Genet., 21, 2211&#x2013;2218.</Citation><ArticleIdList><ArticleId IdType="pubmed">22337953</ArticleId></ArticleIdList></Reference><Reference><Citation>Toulouse, A., Au-Yeung, F., Gaspar, C., Roussel, J., Dion, P. and Rouleau, G.A. (2005) Ribosomal frameshifting on MJD-1 transcripts with long CAG tracts. Hum. Mol. Genet., 14, 2649&#x2013;2660.</Citation><ArticleIdList><ArticleId IdType="pubmed">16087686</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen, L., Cleary, J.D. and Ranum, L.P.W. (2019) Repeat-associated non-ATG translation: molecular mechanisms and contribution to neurological disease. Annu. Rev. Neurosci., 42, 227&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6687071</ArticleId><ArticleId IdType="pubmed">30909783</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng, W., Wang, S., Mestre, A.A., Fu, C., Makarem, A., Xian, F., Hayes, L.R., Lopez-Gonzalez, R., Drenner, K., Jiang, J., et al. (2018) C9ORF72 GGGGCC repeat-associated non-AUG translation is upregulated by stress through eIF2&#x3b1; phosphorylation. Nat. Commun., 9, 51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5754368</ArticleId><ArticleId IdType="pubmed">29302060</ArticleId></ArticleIdList></Reference><Reference><Citation>Jazurek-Ciesiolka, M., Ciesiolka, A., Komur, A.A., Urbanek-Trzeciak, M.O., Krzyzosiak, W.J. and Fiszer, A. (2020) RAN translation of the expanded CAG repeats in the SCA3 disease context. J. Mol. Biol., 432, 166699.</Citation><ArticleIdList><ArticleId IdType="pubmed">33157084</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearse, M.G., Green, K.M., Krans, A., Rodriguez, C.M., Linsalata, A.E., Goldstrohm, A.C. and Todd, P.K. (2016) CGG repeat-associated non-AUG translation utilizes a cap-dependent scanning mechanism of initiation to produce toxic proteins. Mol. Cell, 62, 314&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4854189</ArticleId><ArticleId IdType="pubmed">27041225</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonobe, Y., Ghadge, G., Masaki, K., Sendoel, A., Fuchs, E. and Roos, R.P. (2018) Translation of dipeptide repeat proteins from the C9ORF72 expanded repeat is associated with cellular stress. Neurobiol. Dis., 116, 155&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6331062</ArticleId><ArticleId IdType="pubmed">29792928</ArticleId></ArticleIdList></Reference><Reference><Citation>Hekmat-Scafe, D.S., Dang, K.N. and Tanouye, M.A. (2005) Seizure suppression by gain-of-function escargot mutations. Genetics, 169, 1477&#x2013;1493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1449553</ArticleId><ArticleId IdType="pubmed">15654097</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk, L. and Bonini, N.M. (2012) Protein interacting with C kinase (PICK1) is a suppressor of spinocerebellar ataxia 3-associated neurodegeneration in Drosophila. Hum. Mol. Genet., 21, 76&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3235011</ArticleId><ArticleId IdType="pubmed">21949352</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk, L., Rifai, O.M. and Bonini, N.M. (2020) TDP-43, a protein central to amyotrophic lateral sclerosis, is destabilized by tankyrase-1 and -2. J. Cell Sci., 133, jcs245811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7328137</ArticleId><ArticleId IdType="pubmed">32409565</ArticleId></ArticleIdList></Reference><Reference><Citation>Warrick, J.M., Morabito, L.M., Bilen, J., Gordesky-Gold, B., Faust, L.Z., Paulson, H.L. and Bonini, N.M. (2005) Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism. Mol. Cell, 18, 37&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">15808507</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>